Zacks Investment ResearchWed, 08 Jul 2026 17:01:07 GMTAll You Need to Know About Veracyte (VCYT) Rating Upgrade to Strong BuyVCYT-3.93%
The Motley FoolSat, 04 Jul 2026 13:05:01 GMTA Veracyte Insider Sold 24,000 Company Shares for $1.1 Million. Here's a Deeper Look at the Transaction.VCYT-3.93%
Zacks Investment ResearchThu, 02 Jul 2026 19:16:15 GMTVeracyte Stock Surges 117% in a Year: What's Driving the Rally?VCYT-3.93%
The Motley FoolSat, 27 Jun 2026 16:49:43 GMTWhat to Know About This $197,000 Veracyte Insider Sale After a 120% Stock RallyVCYT-3.93%
Investors Business DailyTue, 16 Jun 2026 12:00:22 GMTThis Top Biotech Has Surged. CEO Explains Key To Veracyte's Success.VCYT-3.93%
Zacks Investment ResearchThu, 11 Jun 2026 14:52:09 GMTWhy Veracyte (VCYT) is a Top Momentum Stock for the Long-TermVCYT-3.93%
Zacks Investment ResearchTue, 09 Jun 2026 14:46:09 GMTHere's Why Veracyte (VCYT) is a Strong Growth StockVCYT-3.93%
Zacks Investment ResearchThu, 04 Jun 2026 16:35:47 GMTWhy Is Veracyte (VCYT) Up 18.2% Since Last Earnings Report?VCYT-3.93%
Seeking AlphaMon, 01 Jun 2026 21:14:08 GMTVeracyte, Inc. (VCYT) Discusses ASCO Findings From OPTIMA and ENZAMET Phase III Trials in Breast and Prostate Cancer TranscriptVCYT-3.93%
Seeking AlphaThu, 28 May 2026 09:17:46 GMTVeracyte: The Evidence Flywheel Is Turning Into A Cash Flow PlatformVCYT-3.93%
Zacks Investment ResearchWed, 27 May 2026 16:11:15 GMTIs it Worth Retaining Veracyte Stock in Your Portfolio for Now?VCYT-3.93%
Zacks Investment ResearchMon, 25 May 2026 16:20:16 GMTVeracyte Stock Surges 65.8% in a Year: What's Driving the Rally?VCYT-3.93%
Zacks Investment ResearchMon, 25 May 2026 14:51:10 GMTHere's Why Veracyte (VCYT) is a Strong Momentum StockVCYT-3.93%
Zacks Investment ResearchMon, 18 May 2026 14:45:37 GMTWhy Veracyte (VCYT) is a Top Growth Stock for the Long-TermVCYT-3.93%
The Motley FoolFri, 08 May 2026 04:51:25 GMTWhy Veracyte Stock Is Skyrocketing Higher This WeekVCYT-3.93%
Zacks Investment ResearchThu, 07 May 2026 14:31:34 GMTVeracyte (VCYT) Crossed Above the 200-Day Moving Average: What That Means for InvestorsVCYT-3.93%
Seeking AlphaWed, 06 May 2026 02:51:14 GMTVeracyte, Inc. (VCYT) Q1 2026 Earnings Call TranscriptVCYT-3.93%
Zacks Investment ResearchWed, 06 May 2026 01:36:04 GMTVeracyte (VCYT) Beats Q1 Earnings and Revenue EstimatesVCYT-3.93%
Zacks Investment ResearchTue, 05 May 2026 14:55:40 GMTWall Street Analysts Think Veracyte (VCYT) Could Surge 39.16%: Read This Before Placing a BetVCYT-3.93%
Zacks Investment ResearchMon, 27 Apr 2026 14:31:02 GMTVeracyte (VCYT) Recently Broke Out Above the 50-Day Moving AverageVCYT-3.93%
